Form 10-K OncoMed Pharmaceuticals For: Dec 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq hits record high after softer jobs data cuts rate-hike bets
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
OncoMed Pharma (OMED) Misses Q4 EPS by 23c
March 12, 2015 4:51 PM EDTOncoMed Pharma (NASDAQ: OMED) reported Q4 EPS of ($0.50), $0.23 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.52 million versus the consensus estimate of $18.2 million.
For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.
... More